Drug details

Gemtesa (vibegron tablets)

type of Beta3 Agonists

Gemtesa (vibegron) is a beta-3 adrenergic agonist used to treat overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.

The drug is often used to treat Urinary incontinence .

This drug may have the following side effects:

• diarrhea,
• headache,
• urinary tract infection (UTI),
• runny or stuffy nose,
• upper respiratory tract infection
• nausea, and

The following drugs are related to Gemtesa, either as a replacement or used together:

• Enablex (darifenacin extended-release tablets)
• Detrol (tolterodine tartrate)
• Detrol LA (tolterodine tartrate)
• Ditropan (oxybutynin tablets)
• Ditropan XL (oxybutynin chloride extended release tablets)
• Toviaz (fesoterodine fumarate extended-release tablets)
• Oxytrol (oxybutynin transdermal)
• Sanctura (trospium chloride tablets)
• Sanctura XR (trospium chloride extended release capsule)
• VESIcare (solifenacin succinate)
• VESIcare LS (solifenacin succinate oral solution)